4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Beta Bionics, Inc. (BBNX) operates in the Medical Devices industry and is headquartered in Irvine, United States with about 420 employees. Its market capitalization is roughly $751 million. In the fiscal year ended 2025-12-31, BBNX reported $100M in revenue and ($73M) in net income.
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes.
Interactive charts & full statements → Open the BBNX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $100M | $65M | $12M | $0M |
| Gross Profit | $56M | $36M | $6M | $0M |
| Operating Income (EBIT) | ($72M) | ($45M) | ($36M) | ($66M) |
| Net Income | ($73M) | ($55M) | ($44M) | ($65M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $28M | $32M | $27M | $23M | $18M | — |
| Gross Profit | $16M | $19M | $15M | $12M | $9M | — |
| Operating Income (EBIT) | ($24M) | ($16M) | ($17M) | ($20M) | ($19M) | — |
| Net Income | ($22M) | ($14M) | ($14M) | ($17M) | ($29M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $329M | $150M | $110M | $36M |
| Total Liabilities | $41M | $395M | $313M | $206M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BBNX viewer.
About TickerBase · Data methodology & sources